Ann: Sale of IOT Solutions Business to Inpixon, page-52

I agree, as a reminder, the primary customer of Sensera, Abiomed, Inc (market cap 13bn) promptly received FDA EUA approval for their Impella heart pump device under the auspices of the Covid-19 pandemic. I think it bodes very well for Sensera also receiving approval.

Like you have stated, this company isn't a one trick pony. Existing product development relationships with Abiomed, DoD, Chuxing Technology, Braemac and others including partnerships with Harvard University and MIT.

MEMS is rapidly growing sector with new applications coming to the market at an astronomical rate.